Search

Your search keyword '"VIRAL ENTRY"' showing total 5,958 results

Search Constraints

Start Over You searched for: Descriptor "VIRAL ENTRY" Remove constraint Descriptor: "VIRAL ENTRY" Topic viruses Remove constraint Topic: viruses
5,958 results on '"VIRAL ENTRY"'

Search Results

1. The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus.

2. Molecular mimicry of host short linear motif-mediated interactions utilised by viruses for entry.

3. Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin?

4. Role of Protein-Lipid Interactions in Viral Entry.

5. Potential Antiviral Action of Alkaloids.

6. Broad-spectrum Respiratory Virus Entry Inhibitors.

7. Viral entry and the ubiquitin-proteasome system.

8. Ephrin-Eph signaling usage by a variety of viruses.

9. Virus-Receptor Interactions: The Key to Cellular Invasion.

10. Polyphenolic Natural Products Active In Silico Against SARS-CoV-2 Spike Receptor Binding Domains and Non-structural Proteins - A Review

11. Different impact of bovine complement regulatory protein 46 (CD46bov) as a cellular receptor for members of the species Pestivirus H and Pestivirus G

12. Innate immunology in COVID-19--a living review. Part I: viral entry, sensing and evasion.

13. Macropinocytosis Dependent Entry of Chikungunya Virus into Human Muscle Cells.

14. Vaccinia viral A26 protein is a fusion suppressor of mature virus and triggers membrane fusion through conformational change at low pH.

15. Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.

16. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.

17. Building a mechanistic mathematical model of hepatitis C virus entry.

18. Targeting Chikungunya Virus Entry: Alternatives for New Inhibitors in Drug Discovery

19. Dengue Virus Entry/Fusion Inhibition By Small Bioactive Molecules: A Critical Review

20. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection

21. SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response

22. Effects of epigallocatechin-3-gallate and acyclovir on herpes simplex virus type 1 infection in oral epithelial cells

23. Virus structure and structure-based antivirals

24. Antivirals targeting paramyxovirus membrane fusion

25. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2

26. Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management

27. Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2

28. Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function

29. Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells

30. Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro

31. Virus transmission and epidemiology

32. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.

33. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.

34. Blockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies.

35. Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women.

36. Probing structural changes in single enveloped virus particles using nano-infrared spectroscopic imaging.

37. Bluetongue virus capsid protein VP5 perforates membranes at low endosomal pH during viral entry

38. Molecular Profiling of Neprilysin Expression and its Interactions with SARS-CoV-2 Spike Proteins to Develop Evidence Base Pharmacological Approaches for Therapeutic Intervention

39. In Silico Drug Discovery of 4-Hyroxypanduratin A, 6-Gingerol and Luteolin Targeting Nipah Virus

40. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target

41. VThunter: a database for single-cell screening of virus target cells in the animal kingdom

42. Modulation of host cell signaling during cytomegalovirus latency and reactivation

43. Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets

44. Structure dynamics of HIV-1 Env trimers on native virions engaged with living T cells

45. In silico analysis of Trisindoline 1 compound against Mpro SARS-CoV-2 as novel potential drugs candidate

46. Host proviral and antiviral factors for SARS-CoV-2

47. Neutralizing antibodies for the prevention and treatment of COVID-19

48. Physicochemical tools for studying virus interactions with targeted cell membranes in a molecular and spatiotemporally resolved context

49. Palmitoylation of SARS‐CoV‐2 S protein is critical for S‐mediated syncytia formation and virus entry

50. Identification of brevinin-1EMa-derived stapled peptides as broad-spectrum virus entry blockers

Catalog

Books, media, physical & digital resources